rhIL-15
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for rhIL-15, covering 2023-03-06 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma [Phase 1]